Piramal Pharma Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide.
One of their notable products is DESMOPRESSIN ACETATE, with a corresponding US DMF Number 22871.
Remarkably, this DMF maintains an Active status since its submission on June 16, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 16, 2014, and payment made on December 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II